| Product Name | NebuSelect™ Recombinant Human VIPR2, mFc-tag |
|---|---|
| Catalog Number | NBL-241302 |
| Alias/Synonyms | VIPR2 |
| Appearance | see COA |
| Molecule Weight | Glu24-Val126 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | P41587-1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-241302-100ug | 100ug | Inquire | Inquire | |
| NBL-241302-1mg | 1mg | Inquire | Inquire | |
| NBL-241302-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human VIPR2, mFc-tag
Catalog#:
NBL-241302
Description:
NebuSelect™ Recombinant Human VIPR2, mFc-tag(Cat#NBL-241302) is expressed in HEK293 with mFc tag at the C-terminus.It contains Glu24-Val126.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 37.35 kDa. Due to glycosylation, the protein migrates to 45-60 kDa based on Bis-Tris PAGE result.
Target Name:
VIPR2
Target Information:
Effects of vasoactive intestinal peptide (VIP) on T cell migration are mediated by structurally distinct types I (VIPR1) and II (VIPR2) G protein-associated receptors. The two receptor types were proposed to transduce opposite effects on human T cells, since cytokine-induced chemotaxis of VIPR1-bearing HuT 78 human T cells, in contrast to T cells that express VIPR2, was inhibited by VIP.
Amino Acid Sequence:
Glu24-Val126
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.